Free tool
FAERS Monitor: Dobutamine Hydrochloride In Dextrose 5% In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020201 or its brand name (Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Dobutamine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
4
Serious
1
25% of reports
Hospitalization
1
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- asthenia1
- blood pressure increased1
- burkholderia test positive1
- device issue1
- dizziness1
- drug monitoring procedure not performed1
- drug therapeutic incompatibility1
- heart rate increased1
- product deposit1
- product packaging confusion1
- wrong product stored1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2020 | 1 |
| 2022 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,155 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| burkholderia test positive | 1 | 42793.0 | 7766.3 | 10,611 |
| drug therapeutic incompatibility | 1 | 34402.2 | 6254.7 | 8,544 |
| wrong product stored | 1 | 18599.1 | 3393.0 | 4,632 |
| product deposit | 1 | 3378.4 | 618.3 | 843 |
| drug monitoring procedure not performed | 1 | 2929.1 | 536.1 | 731 |
| product packaging confusion | 1 | 2167.0 | 396.7 | 541 |
| device issue | 1 | 58.6 | 10.7 | 14 |
| heart rate increased | 1 | 53.1 | 9.7 | 12 |
| blood pressure increased | 1 | 34.4 | 6.3 | 8 |
| asthenia | 1 | 14.0 | 2.6 | 3 |
| dizziness | 1 | 10.5 | 1.9 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.